Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 139,626 | 169,945 | 344,709 | 86,572 | 148,363 |
| Marketable Securities | 222,194 | 222,823 | 156,387 | 143,910 | 101,316 |
| Receivables | 6,906 | 11,955 | 12,782 | 26,754 | 40,086 |
| Inventories | 12,126 | 13,215 | 12,220 | 12,480 | 9,810 |
| TOTAL | $384,882 | $421,504 | $528,503 | $274,035 | $303,125 |
| Non-Current Assets | |||||
| PPE Net | 8,679 | 8,251 | 8,460 | 8,832 | 8,811 |
| Investments And Advances | 144,445 | 155,885 | 99,565 | 66,769 | 60,316 |
| Other Non-Current Assets | 5,880 | 2,399 | 2,726 | 6,653 | 2,236 |
| TOTAL | $159,004 | $166,535 | $110,751 | $82,254 | $71,363 |
| Total Assets | $543,886 | $588,039 | $639,254 | $356,289 | $374,488 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,406 | 3,626 | 1,733 | 5,351 | 7,412 |
| Accrued Expenses | 15,800 | 9,131 | 14,021 | 11,887 | 9,020 |
| TOTAL | $57,103 | $48,984 | $49,268 | $45,410 | $44,657 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 142 | 142 | 152 | 218 | 662 |
| Other Non-Current Liabilities | 242,206 | 241,435 | 235,789 | 8,847 | 3,878 |
| TOTAL | $245,656 | $245,109 | $239,755 | $13,006 | $8,247 |
| Total Liabilities | $302,759 | $294,093 | $289,023 | $58,416 | $52,904 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,829 | 53,361 | 52,855 | 51,942 | 47,852 |
| Common Shares | 1 | 1 | 1 | N/A | N/A |
| Retained earnings | -643,941 | -577,654 | -512,225 | -444,892 | -410,931 |
| Other shareholders' equity | -248 | -272 | -253 | 39 | 181 |
| TOTAL | $241,127 | $293,946 | $350,231 | $297,873 | $321,584 |
| Total Liabilities And Equity | $543,886 | $588,039 | $639,254 | $356,289 | $374,488 |